Treace Medical Concepts Inc (TMCI)

$6.72 +0.06 (0.90%)
Market Cap 422.62M
Revenue (ttm) 209.36M
Net Income (ttm) -55.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -26.62%
Debt to Equity Ratio 0.47
Volume 422,800
Avg Vol 390,830
Day's Range N/A - N/A
Shares Out 62.89M
Stochastic %K 65%
Beta 0.77
Analysts Sell
Price Target $26.64

Latest News on TMCI

Treace to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 4:05 PM EDT - 2 days ago

Treace to Report First Quarter 2025 Financial Results on May 8, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

Apr 19, 2025, 9:43 AM EDT - 7 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference

Mar 28, 2025, 2:00 PM EDT - 4 weeks ago

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference

Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference

Mar 25, 2025, 4:15 PM EDT - 4 weeks ago

Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference

The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation

Mar 1, 2025, 11:00 AM EST - 2 months ago

The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation

Treace Medical Concepts, Inc. (TMCI) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 1:11 PM EST - 2 months ago

Treace Medical Concepts, Inc. (TMCI) Q4 2024 Earnings Call Transcript

Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Feb 6, 2025, 4:15 PM EST - 2 months ago

Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

The Schall Law Firm Invites Investors With Losses To Join An Investigation Into Treace Medical Concepts, Inc. For Securities Fraud

Feb 2, 2025, 11:00 AM EST - 2 months ago

The Schall Law Firm Invites Investors With Losses To Join An Investigation Into Treace Medical Concepts, Inc. For Securities Fraud

Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm

Jan 30, 2025, 11:00 AM EST - 3 months ago

Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm

Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

Jan 23, 2025, 12:45 PM EST - 3 months ago

Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Jan 19, 2025, 11:00 AM EST - 3 months ago

Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud

Jan 18, 2025, 11:15 AM EST - 3 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud

The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors

Jan 9, 2025, 12:07 PM EST - 3 months ago

The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts Inc For Securities Fraud

Jan 3, 2025, 1:15 PM EST - 4 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts Inc For Securities Fraud

Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 4:15 PM EST - 4 months ago

Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference

The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts Inc For Securities Fraud

Dec 31, 2024, 12:30 PM EST - 4 months ago

The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts Inc For Securities Fraud

Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure

Dec 30, 2024, 8:15 AM EST - 4 months ago

Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure